Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect?Zacks Investment Research • 05/13/24
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ETGlobeNewsWire • 04/26/24
After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX)Zacks Investment Research • 04/23/24
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)Zacks Investment Research • 04/22/24
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 04/16/24
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ETGlobeNewsWire • 03/25/24
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023GlobeNewsWire • 03/11/24
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach EffortGlobeNewsWire • 03/04/24
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving LandscapeGlobeNewsWire • 01/25/24
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business UpdateGlobeNewsWire • 01/09/24
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San FranciscoGlobeNewsWire • 12/18/23
OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 12/11/23
Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should KnowZacks Investment Research • 12/06/23
How Much Upside is Left in OptimizeRx Corp. (OPRX)? Wall Street Analysts Think 47.72%Zacks Investment Research • 11/20/23
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/30/23